Waters Waters Q2 Revenues up 31 Percent The company posted revenues of $681.6 million, up 31 percent from $520.0 million in Q2 2020, and above the average Wall Street estimate of $621.5 million. Evercore ISI Upgrades Waters to Outperform Based on Improved Fundamentals The analysts cited opportunity in drug QC provided by Biogen's aducanumab approval as well as a new focus on markets like CROs and CDMOs. Waters, SISCAPA Assay Technologies Develop Mass Spec Test for SARS-CoV-2 Premium The companies said that they envisioned the test, which is currently RUO, as potentially part of a mass spectrometry-based respiratory virus panel. New Mass Spec Releases Target Single-Cell, Imaging Proteomics Work Premium Vendors including Bruker, Sciex, and Waters this month launched instruments featuring new technologies boosting sensitivity and resolution. New Products Posted to GenomeWeb: Fluidigm, Waters, MicroGenDx, More May 11, 2021 Sciex, Waters Partner to Provide Interoperable LC-MS Systems May 5, 2021 Waters Posts 31 Percent Increase in Q1 Revenues Mar 4, 2021 Waters Enters $500M Senior Notes Private Placement Feb 2, 2021 Waters Revenues up 10 Percent in Q4, Down 2 Percent in 2020 Jan 13, 2021 JP Morgan Healthcare Conference 2021, Day 1: Qiagen, Invitae, Agilent, Sema4, More Oct 27, 2020 Waters Q3 Revenues Up 3 Percent Jul 28, 2020 Waters Q2 Revenues Fall 13 Percent, Beat Wall Street Estimate Jul 15, 2020 Waters Reports Preliminary Q2 Revenue Drop of 13 to 14 Percent, Names New CEO Jul 2, 2020 Surge in Stocks of SARS-CoV-2 Dx Developers Pushes GenomeWeb Index Up 15 Percent in H1 2020 Jul 1, 2020 Invitae Stock Skyrockets in June on ArcherDx Acquisition, Leading GenomeWeb Index Jun 19, 2020 People in the News: Geoffrey Oxnard, Christopher O'Connell, Thierry Bernard, More Jun 12, 2020 2020 ASMS Goes Virtual With Emphasis on Software, Workflow Advances Premium Apr 28, 2020 Waters Q1 Revenues Down 10 Percent Feb 4, 2020 Waters Reports Flat Revenues for Q4, 1 Percent Decline for 2019 Jan 15, 2020 The Decade in Proteomics: Most Significant New Instrumentation Premium Jan 2, 2020 In 2019, Gains in Throughput Position Proteomics for Future Clinical Impact Premium Oct 29, 2019 Waters Q3 Revenues Flat, Fall Short of Expectations Oct 9, 2019 Waters Stock Downgraded by Barclays Sep 30, 2019 Bioanalytical Instrumentation Firm Creoptix Raises CHF 8M Aug 29, 2019 Mass Spec Instrument Advances Are Cause for Optimism in Top-Down Proteomics Premium Load More Breaking News Beckman Coulter, Invitae Partner to Develop NGS Library Prep Applications Sick Infants Profiled with WGS See Better Diagnosis, More Care Changes UC Santa Cruz Center for Live Cell Genomics Wins $13.5M NIH Grant Genetron Health, Impact Therapeutics Partner for Anti-Cancer Drug, CDx Development Canaccord Genuity Initiates Coverage of Pacific Biosciences With Buy Rating Alternative Genetic Counseling Approach Leads to Higher Patient Satisfaction, Study Suggests The Scan Highly Similar Researchers have uncovered bat viruses that are highly similar to SARS-CoV-2, according to Nature News. Gain of Oversight According to the Wall Street Journal, the Biden Administration is considering greater oversight of gain-of-function research. Lasker for mRNA Vaccine Work The Scientist reports that researchers whose work enabled the development of mRNA-based vaccines are among this year's Lasker Award winners PLOS Papers on Causal Variant Mapping, Ancient Salmonella, ALK Fusion Test for NSCLC In PLOS this week: MsCAVIAR approach to map causal variants, analysis of ancient Salmonella, and more.